financetom
Business
financetom
/
Business
/
US FDA places clinical hold on Tenaya Therapeutics' gene therapy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA places clinical hold on Tenaya Therapeutics' gene therapy
Nov 7, 2025 1:55 PM

Nov 7 (Reuters) - The U.S. Food and Drug Administration

has placed a clinical hold on Tenaya Therapeutics' ( TNYA )

trial of its experimental gene therapy for a type of inherited

heart disease, the company said on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jim Cramer: This Is The Right Time To Buy This Energy Stock
Jim Cramer: This Is The Right Time To Buy This Energy Stock
Sep 11, 2025
On CNBC's “Mad Money Lightning Round,” Jim Cramer said this is the right time to buy Phillips 66 . As per the recent news, Phillips 66, on Tuesday, announced it entered into a definitive agreement to acquire the remaining 50% ownership interest in WRB Refining LP from subsidiaries of Cenovus Energy. Tandem Diabetes Care ( TNDM ) is a “speculative...
Euro Continues to Consolidate at Stronger Levels Ahead of ECB Update, Notes Mitsubishi UFG
Euro Continues to Consolidate at Stronger Levels Ahead of ECB Update, Notes Mitsubishi UFG
Sep 11, 2025
07:51 AM EDT, 09/11/2025 (MT Newswires) -- The main event on Thursday will be the European Central Bank's latest policy meeting, said MUFG. Ahead of the meeting, the euro (EUR) has been consolidating against both the US dollar (USD) and sterling (GBP), wrote the bank in a note to clients. For the last couple of months, EUR/USD has been trading...
Form 8.3 - Deliveroo plc
Form 8.3 - Deliveroo plc
Sep 11, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...
Giyani Metals Names Nigel Robinson Interim Executive Chair as Charles FitzRoy Departs
Giyani Metals Names Nigel Robinson Interim Executive Chair as Charles FitzRoy Departs
Sep 11, 2025
07:47 AM EDT, 09/11/2025 (MT Newswires) -- Giyani Metals ( CATPF ) Wednesday said it appointed Nigel Robinson as interim executive chair, replacing Charles FitzRoy, who is leaving to pursue other opportunities. Robinson, who became chair in June, will expand his role as the company advances production of high-purity manganese sulphate monohydrate (HPMSM), progresses offtake negotiations, and works on its...
Copyright 2023-2026 - www.financetom.com All Rights Reserved